RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CRINò L
Collezione AOU San Luigi di Orbassano

Items : 14

Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM). in Tumori / Tumori. 2019 Jul;105(5_suppl):3-14. doi: 10.1177/0300891619857418.

2019
AOU San Luigi di Orbassano

Facchinetti F; Pilotto S; Metro G; Baldini E; Bertolaccini L; Cappuzzo F; Delmonte A; Gasparini S; Inno A; Marchetti A; Passiglia F; Puma F; Ricardi U; Rossi A; Crinò L; Novello S;

Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2015 Sep;10(9):1341-1348. doi: 10.1097/JTO.0000000000000628.

2015
AOU San Luigi di Orbassano

Pilotto S; Sperduti I; Novello S; Peretti U; Milella M; Facciolo F; Vari S; Leuzzi G; Vavalà T; Marchetti A; Mucilli F; Crinò L; Puma F; Kinspergher S; Santo A; Carbognin L; Brunelli M; Chilosi M; Scarpa A; Tortora G; Bria E;

Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Nov;90(2):234-42. doi: 10.1016/j.lungcan.2015.08.005. Epub 2015 Aug 19.

2015
AOU San Luigi di Orbassano

Barni S; Maiello E; Di Maio M; Ardizzoni A; Cappuzzo F; Maranzano E; Novello S; Bennati C; Ori A; Rizzoli S; Crinò L;

ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: results of the first italian external quality assurance scheme. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2014 Oct;9(10):1470-6. doi: 10.1097/JTO.0000000000000280.

2014
AOU San Luigi di Orbassano

Marchetti A; Barberis M; Papotti M; Rossi G; Franco R; Malatesta S; Buttitta F; Ardizzoni A; Crinò L; Gridelli C; Taddei GL; Clemente C; Scagliotti G; Normanno N; Pinto C;

Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2014 May;9(5):733-7. doi: 10.1097/JTO.0000000000000120.

2014
AOU San Luigi di Orbassano

Gridelli C; Novello S; Zilembo N; Luciani A; Favaretto AG; De Marinis F; Genestreti G; Crinò L; Grossi F; Caffo O; Ferraù F; Cruciani G; Brandes AA; Galetta D; Barni S; Fasola G; Cerea G; Ferrari S; Iannacone C; Ciardiello F;

The role of histology with common first-line regimens for advanced non-small cell lung cancer: a brief report of the retrospective analysis of a three-arm randomized trial. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2009 Dec;4(12):1568-71. doi: 10.1097/JTO.0b013e3181c06980.

2009
AOU San Luigi di Orbassano

Scagliotti GV; De Marinis F; Rinaldi M; Crinò L; Gridelli C; Ricci S; Zhao YD; Liepa AM; Peterson P; Tonato M;

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2007 May;18(5):903-8. doi: 10.1093/annonc/mdm061. Epub 2007 Mar 9.

2007
AOU San Luigi di Orbassano

Novello S; Bruzzi P; Barone C; Buosi R; Masotti A; Michetti G; Fioretti M; Barbera S; Spatafora M; Garetto L; Mazzanti P; Dongiovanni V; Selvaggi G; Crinò L; Scagliotti GV;

Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):690-6.

2005
AOU San Luigi di Orbassano

Scagliotti GV; Kortsik C; Dark GG; Price A; Manegold C; Rosell R; O'Brien M; Peterson PM; Castellano D; Selvaggi G; Novello S; Blatter J; Kayitalire L; Crino L; Paz-Ares L;

Pemetrexed in front-line chemotherapy for advanced non-small-cell lung cancer. in Oncology (Williston Park, N.Y.) / Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):32-7.

2004
AOU San Luigi di Orbassano

Scagliotti GV; Novello S; Crino L; Rosell R;

Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2003 Oct 1;95(19):1453-61. doi: 10.1093/jnci/djg059.

2003
AOU San Luigi di Orbassano

Scagliotti GV; Fossati R; Torri V; Crinò L; Giaccone G; Silvano G; Martelli M; Clerici M; Cognetti F; Tonato M;

Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Nov;34(2):261-9. doi: 10.1016/s0169-5002(01)00238-0.

2001
AOU San Luigi di Orbassano

Novello S; Galli L; Antonuzzo A; Crinó L; Pozzi E; Selvaggi G; Ricci S; Marrocolo F; Darwish S; Sorbolini S; Tonato M; Scagliotti GV;

Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 1999 Jul;25(1):39-46. doi: 10.1016/s0169-5002(99)00048-3.

1999
AOU San Luigi di Orbassano

Scagliotti GV; Crinó L; Pozzi E; Corgna E; Selvaggi G; Novello S; Salsano G; Gentile A; Palladino M; Marracolo F; Tonato M;

Chemotherapy of non-small cell lung cancer. in Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Monaldi Arch Chest Dis. 1997 Jun;52(3):287-95.

1997
AOU San Luigi di Orbassano

Scagliotti GV; Crinò L;

Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 1996;38(6):561-5. doi: 10.1007/s002800050527.

1996
AOU San Luigi di Orbassano

Scagliotti GV; Ricardi U; Crinó L; Maranzano E; De Marinis F; Morandi MG; Meacci L; Marangolo M; Emiliani E; Rosti G; Figoli F; Bolzicco G; Masiero P; Gentile A; Tonato M;